These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The effect of dried plum on serum levels of receptor activator of NF-κB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial. Hooshmand S; Brisco JR; Arjmandi BH Br J Nutr; 2014 Jul; 112(1):55-60. PubMed ID: 24780728 [TBL] [Abstract][Full Text] [Related]
44. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME J Nephrol; 2009; 22(6):774-82. PubMed ID: 19967657 [TBL] [Abstract][Full Text] [Related]
45. Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes. Altinova AE; Toruner F; Akturk M; Bukan N; Yetkin I; Cakir N; Arslan M Scand J Clin Lab Invest; 2011 Jul; 71(4):340-3. PubMed ID: 21486111 [TBL] [Abstract][Full Text] [Related]
46. Relationship between aortic pulse wave velocity, selected proinflammatory cytokines, and vascular calcification parameters in peritoneal dialysis patients. Krzanowski M; Janda K; Dumnicka P; Dubiel M; Stompór M; Kuśnierz-Cabala B; Grodzicki T; Sułowicz W J Hypertens; 2014 Jan; 32(1):142-8. PubMed ID: 24309487 [TBL] [Abstract][Full Text] [Related]
47. [The relationships between changes of serum osteoprotegerin, nuclear factor-kappa B ligand receptor activator, and age, menopause, bone biochemical markers and bone mineral densities in women aged 20 - 75]. Liu JM; Zhao HY; Ning G; Zhao YJ; Chen Y; Zhang LZ; Xu MY; Chen JL Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):447-50. PubMed ID: 15312444 [TBL] [Abstract][Full Text] [Related]
48. Arterial wave reflections and mortality in haemodialysis patients--only relevant in elderly, cardiovascularly compromised? Covic A; Mardare N; Gusbeth-Tatomir P; Prisada O; Sascau R; Goldsmith DJ Nephrol Dial Transplant; 2006 Oct; 21(10):2859-66. PubMed ID: 16854850 [TBL] [Abstract][Full Text] [Related]
49. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus. Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J; J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903 [TBL] [Abstract][Full Text] [Related]
50. Noninvasive arterial measurements of vascular damage in healthy young adults: relation to coronary heart disease risk. Van Trijp MJ; Uiterwaal CS; Bos WJ; Oren A; Grobbee DE; Bots ML Ann Epidemiol; 2006 Feb; 16(2):71-7. PubMed ID: 16305824 [TBL] [Abstract][Full Text] [Related]
51. Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. Mogelvang R; Pedersen SH; Flyvbjerg A; Bjerre M; Iversen AZ; Galatius S; Frystyk J; Jensen JS Am J Cardiol; 2012 Feb; 109(4):515-20. PubMed ID: 22100028 [TBL] [Abstract][Full Text] [Related]
52. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993 [TBL] [Abstract][Full Text] [Related]
53. Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct. Guldiken B; Guldiken S; Turgut B; Turgut N; Demir M; Celik Y; Arikan E; Tugrul A Thromb Res; 2007; 120(4):511-6. PubMed ID: 17258300 [TBL] [Abstract][Full Text] [Related]
54. Effects of long-term risedronate treatment on serum ferritin levels in postmenopausal women with osteoporosis: the impact of cardiovascular risk factor load. Feldbrin Z; Luckish A; Shargorodsky M Menopause; 2016 Jan; 23(1):55-9. PubMed ID: 26057821 [TBL] [Abstract][Full Text] [Related]
55. [Associations and related factors between pulse wave velocity and arterial system and augmentation index measured on different sites in a healthy population]. Zhang MH; Ye P; Luo LM; Xiao WK; Wu HM; Liu DJ Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov; 38(11):998-1005. PubMed ID: 21215229 [TBL] [Abstract][Full Text] [Related]
56. The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. Davenport C; Kenny H; Ashley DT; O'Sullivan EP; Smith D; O'Gorman DJ Eur J Clin Invest; 2012 Nov; 42(11):1173-9. PubMed ID: 22803952 [TBL] [Abstract][Full Text] [Related]
57. Advanced glycation end-products and arterial stiffness in hypertension. McNulty M; Mahmud A; Feely J Am J Hypertens; 2007 Mar; 20(3):242-7. PubMed ID: 17324733 [TBL] [Abstract][Full Text] [Related]
58. Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women. Nabipour I; Kalantarhormozi M; Larijani B; Assadi M; Sanjdideh Z Metabolism; 2010 May; 59(5):742-7. PubMed ID: 19922962 [TBL] [Abstract][Full Text] [Related]
59. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. Anand DV; Lahiri A; Lim E; Hopkins D; Corder R J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312 [TBL] [Abstract][Full Text] [Related]
60. Arterial stiffness, central blood pressures, and wave reflections in cardiomyopathy-implications for risk stratification. Weber T; Auer J; Lamm G; O'Rourke MF; Eber B J Card Fail; 2007 Jun; 13(5):353-9. PubMed ID: 17602981 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]